DJE - Equity Market Neutral Europe XP (EUR)

DJE - Equity Market Neutral Europe XP (EUR) Header Image
Minimum investment: 3,000,000 EUR
As at:
95.67 EUR
95.67 EUR

Investment approach

The basic idea of DJE - Equity Market Neutral Europe is the conviction that an active selection of sectors and individual shares is superior to a benchmark index in the long term and can achieve significant added value. Compared to European equity indices, often comprising several hundred stocks, the fund's portfolio contains only a maximum of 50 positions, which are analysed and selected on the basis of fundamental, monetary and market criteria. Due to their weighting, each individual position has a noticeable influence on the portfolio performance. In addition, the fund management aims to neutralise market risks: Instead of hedging the securities held in the portfolio individually, part of the fund assets is invested in an index derivative. This develops positively when the broad European stock index falls; conversely, it weighs on fund performance when the index rises. Furthermore, the individual securities are weighted approximately equally. This serves to limit the risk of the fund's sector weighting deviating from the broad European equity market to the selection of individual stocks. In this way, the fund aims to achieve the most stable positive performance possible, irrespective of the market environment (no guarantee).


  • Positive returns are also possible in falling markets
  • Low-fluctuation performance through extensive neutralization of market risks
  • Benefit from the growth opportunities of the European stock market
  • The fund management is convinced that each of the 50 selected shares has the potential to outperform the broad market and has a noticeable impact on performance.


  • Equity funds are subject to the valuation fluctuations of the stock market
  • Valuation fluctuations may be greater than the hedges used by the fund management
  • Positive returns cannot be guaranteed
  • Currency risks from equity securities not denominated in Euro

Legal Information / Disclaimer:

Figures subject to revision by the auditors on the reporting dates. The published information does not constitute investment advice or a recommendation, but only provides a brief summary of the key features of the fund. The current sales documents (Key Investor Information Document, prospectus, annual report and – if the annual report is older than eight months – the semi-annual report) for the respective investment funds form the sole basis for the purchase of securities. The sales documents are available at no charge at the respective fund company, the distribution company or at All data and estimates are indicative and may change at any time. This information is based on our assessment of current legal and tax regulations. The data were carefully compiled, but no guarantee can be given for the accuracy of such information. All data are subject to change. The performance is calculated using the BVI (Bundesverband Investment und Asset Management e.V.) method, i.e. without taking into account the subscription fee. Individual expenses such as fees, commissions and other charges are not taken into account in the data and would have a detrimental effect on the performance if they were. The subscription fees payable reduce the invested capital as well as the performance depicted. Data on past performance are not a reliable indicator of future performance. The tax treatment depends on the individual circumstances of the investor and may be subject to change. Please see the prospectus for more detailed tax information. In connection with brokering fund units, the Dr. Jens Ehrhardt Group and its distribution partners may receive reimbursements from costs charged to the funds by the investment companies in accordance with the respective prospectuses. The units of this fund that are issued may only be sold or offered for sale in jurisdictions in which such offer or sale is permitted. Therefore the units of this fund may not be offered for sale or sold in the USA, or offered for sale or sold to or for the account of US citizens or US persons resident in the USA. This document and the information it contains may not be distributed in the USA. The distribution and publication of this document and the offer or sale of units may also be subject to restrictions in other jurisdictions.

*) © 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.